AGN Evening Update | 9th April 2025 – Malaysia Eyes Export Gains, Trump Targets Pharma, India Cuts Rates, Alps Global Advances NKT Therapy
In tonight’s AGN Evening Update, we bring you the key developments shaping regional economies, global pharma supply chains, and cutting-edge cancer treatment innovations.
Malaysia’s Auto Export Strategy
As U.S. tariffs take a toll on Thailand and Indonesia, Malaysia is seizing the moment. With a lower import duty of 24% into the U.S., compared to its regional peers, Malaysia is positioning itself to boost auto exports and narrow a 40-year sector trade deficit. With over 700,000 workers and 700 component manufacturers, the automotive industry is set for new regional momentum.
Trump’s Pharma Tariff Sparks European Alarm
President Trump’s new target: pharmaceutical imports. European pharma leaders, including Bayer and Novartis, fear an exodus of operations to the U.S. as supply chains and innovation pipelines face disruption. With €90 billion in annual exports to the U.S. at stake, the EU is being urged to modernize regulatory frameworks and protect R&D competitiveness.
India Cuts Rates Amid Global Pressure
India’s Reserve Bank cut interest rates by 25 basis points to 6% in response to slowing growth, inflation control, and the impact of Trump’s tariff regime. Analysts now forecast India’s GDP growth at just 6.1% this year — down from previous estimates. The government remains cautious but is actively negotiating new trade terms with the U.S.
Alps Global Holding Leads Biotech With NKT Therapy
On the health front, Alps Global continues to set the pace in precision immunotherapy. Its Natural Killer T (NKT) Cell Therapy combines the precision of NK and T-cell immunity, offering cancer patients a non-toxic, animal-free solution for post-treatment recovery and immune restoration.
Filed under MyIPO Malaysia, this patented platform avoids the risks of CRS and ICANS and is built around next-gen DNA/RNA screening for personalized, multi-cycle treatment plans. With proven effectiveness in lung, breast, colorectal, and gastric cancers, Alps’ innovation is becoming a biotech benchmark in Asia.
📺 Catch the full breakdown now on YouTube:
